END-TO-END CELL THERAPY AUTOMATION

The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system.

Saved in:
Bibliographic Details
Main Authors MCAFEE, Erika, SIEHOFF, Ann, ABRAHAM, Eytan, SHI, Yaling, O'CONNOR, Joseph, PURPURA, Kelly, SMITH, Timothy, GLEISSNER, Timo, TRAINOR, Nuala, BANDAPALLE, Samatha
Format Patent
LanguageEnglish
Published 15.02.2024
Subjects
APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

Abstract The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system.
AbstractList The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system.
Author ABRAHAM, Eytan
SHI, Yaling
SMITH, Timothy
GLEISSNER, Timo
O'CONNOR, Joseph
MCAFEE, Erika
SIEHOFF, Ann
PURPURA, Kelly
BANDAPALLE, Samatha
TRAINOR, Nuala
Author_xml – fullname: MCAFEE, Erika
– fullname: SIEHOFF, Ann
– fullname: ABRAHAM, Eytan
– fullname: SHI, Yaling
– fullname: O'CONNOR, Joseph
– fullname: PURPURA, Kelly
– fullname: SMITH, Timothy
– fullname: GLEISSNER, Timo
– fullname: TRAINOR, Nuala
– fullname: BANDAPALLE, Samatha
BookMark eNrjYmDJy89L5WRQcvVz0Q3x1wVSCs6uPj4KIR6uQY4BkQqOoSH-vo4hnv5-PAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPjTYyMDIxMDUyNjQ0NHQmDhVAJUUJOw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2024052311A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2024052311A13
IEDL.DBID EVB
IngestDate Fri Oct 18 05:53:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2024052311A13
Notes Application Number: US202318496573
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240215&DB=EPODOC&CC=US&NR=2024052311A1
ParticipantIDs epo_espacenet_US2024052311A1
PublicationCentury 2000
PublicationDate 20240215
PublicationDateYYYYMMDD 2024-02-15
PublicationDate_xml – month: 02
  year: 2024
  text: 20240215
  day: 15
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies LONZA COLOGNE GMBH
OCTANE BIOTECH INC
LONZA WALKERSVILLE, INC
RelatedCompanies_xml – name: OCTANE BIOTECH INC
– name: LONZA COLOGNE GMBH
– name: LONZA WALKERSVILLE, INC
Score 3.5166173
Snippet The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells,...
SourceID epo
SourceType Open Access Repository
SubjectTerms APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title END-TO-END CELL THERAPY AUTOMATION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240215&DB=EPODOC&locale=&CC=US&NR=2024052311A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcChV1JtWxUeVoJLbopvdtPEQpM2DIM2DNpF6KpttAoLUYiP-vrMx1Z562sfA7IOdnZ3nAtwhleUGnZeEi74gnHGDCPYgiDSFRHaoct4o1UAY9YKMP0_NaQve17EwdZ7Q7zo5IlKURHqv6vt6-a_EcmvfytV9_oZdH09-art6Ix0rUwE1dXdoe0nsxo7uOHY20aPxLwyFLkoHKCvt4EO6rxzAvJehiktZbjIV_xB2E8S3qI6gVSw6sO-s_17rwF7YmLyx2lDf6hhuvMglaUyw0BxvNNLSwBsPklcND1kc1sqmE7j1vdQJCA42-1vbLJtszoydQhul_uIMtJ71KErJcmZxi_OcKgWNkLJkpVFaFi3OobsN08V28CUcqKZyP6ZmF9rV51dxhdy1yq_rTfkBt0F4XA
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYqXqUWlb0HTprM-FNl6oWpvbJ3Mp5LWFgSZw1X8-57ETve0p4QcyI2cnHznFoAr5LJco68VYfyWE6YzjXD9hpPC4AWKQ5HzRqgGwqjvT9jj1Ji24H0ZCyPzhH7L5IjIUQXyey3v6_m_EsuRvpWL6_wNmz7uvdRy1AYdC1MBNVRnaLlJ7MS2atvWZKxGo18agi5KB4iVNvCRbYpM--7zUMSlzFeFircDmwn2N6t3oVXOutCxl3-vdWErbEzeWG24b7EHF27kkDQmWCi2GwRK6rujQfKi4CGLQ6ls2odLz01tn-Bg2d_assl4dWb6AbQR9ZeHoPTNO14Veq6bzGQsp0JBw4ui0iutMk1aHkFvXU_H68nn0PHTMMiCh-jpBLYFSbgiU6MH7frzqzxFSVvnZ3KDfgCDv3tM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=END-TO-END+CELL+THERAPY+AUTOMATION&rft.inventor=MCAFEE%2C+Erika&rft.inventor=SIEHOFF%2C+Ann&rft.inventor=ABRAHAM%2C+Eytan&rft.inventor=SHI%2C+Yaling&rft.inventor=O%27CONNOR%2C+Joseph&rft.inventor=PURPURA%2C+Kelly&rft.inventor=SMITH%2C+Timothy&rft.inventor=GLEISSNER%2C+Timo&rft.inventor=TRAINOR%2C+Nuala&rft.inventor=BANDAPALLE%2C+Samatha&rft.date=2024-02-15&rft.externalDBID=A1&rft.externalDocID=US2024052311A1